Valiant Co

Valiant Co EBITDA Margin

The EBITDA Margin of Valiant Co (002643.SZ) as of Nov 19, 2026 is 14.19 %. In the previous year, EBITDA Margin was 13.57 % — a change of 4.57% (higher).

EBITDA Margin

14.19 %

YoY

4.57%

Last updated:

EBITDA Margin of Valiant Co is 2025 14.19 % . EBITDA Margin of Valiant Co was 2024 13.57 % . It decreases by 4.57% higher compared to the previous year.

The Valiant Co EBITDA Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Margin
Date
EBITDA Margin
Jan 1, 2018
21.07 CNY
Jan 1, 2019
23.28 CNY
Jan 1, 2020
23.92 CNY
Jan 1, 2021
19.38 CNY
Jan 1, 2022
21.13 CNY
Jan 1, 2023
24.17 CNY
Jan 1, 2024
13.57 CNY
Jan 1, 2025
14.19 CNY
The Valiant Co EBITDA Margin history
YEAREBITDA MarginYoY
14.19 %+4.57%
13.57 %-43.86%
24.17 %+14.40%
21.13 %+9.06%
19.38 %-19.01%
23.92 %+2.75%
23.28 %+10.50%
21.07 %+11.41%
18.91 %-8.33%
20.63 %+8.81%
18.96 %+77.84%
10.66 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valiant Co Stock analysis

What does Valiant Co do? Valiant Co., Ltd. generates revenue through three core business segments. The Information Materials Industry segment produces and sells display materials and functional materials, targeting customers in the electronics and manufacturing sectors. The Environmental Protection Materials Industry segment develops and manufactures new zeolite environmental protection materials for tail gas purification, serving automotive and industrial clients requiring emission control solutions. The Large Health Industry segment focuses on pharmaceutical production, life sciences, and in vitro diagnostic services, catering to healthcare providers and medical facilities. The company's products include display materials, functional materials, new zeolite environmental protection materials, pharmaceuticals, and in vitro diagnostic services. These offerings are sold across the three industry segments, with the Environmental Protection Materials segment specifically addressing tail gas purification needs. The Large Health Industry segment's in vitro diagnostic services support healthcare operations through specialized medical solutions. Valiant Co., Ltd. serves diverse customer segments including electronics manufacturers, automotive industries, industrial emission control clients, and healthcare providers. The firm's revenue streams are derived from the sale of physical products like display materials and zeolite materials, as well as service-based offerings in diagnostics and pharmaceuticals. The company's business model relies on manufacturing and selling these products across its three operational segments. Valiant Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Valiant Co stock

EBITDA Margin of Valiant Co is 14.19 % in 2025.

EBITDA Margin of Valiant Co changed from 13.57 % to 14.19 %, representing a 4.57% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA Margin Valiant Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA Margin shows what percentage of revenue converts to EBITDA. It normalizes for depreciation and capital structure differences.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBITDA Margin's Valiant Co with sector peers and the industry average to assess whether it is attractive.

To evaluate EBITDA Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBITDA Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Valiant Co

All Key Metrics — Valiant Co